期刊文献+

晚期卵巢癌患者肺栓塞猝死临床病理讨论 被引量:2

Clinicopathological Conference:an Advanced Ovarian Carcinoma Patient Suddenly Died of Pulmonary Embolism
下载PDF
导出
摘要 患者60岁,腹部胀痛1个月,开腹手术诊断为卵巢透明细胞癌Ⅲc期,G2。在满意的肿瘤细胞减灭术后,辅以紫杉醇和卡铂联合周疗。第Ⅰ疗程后,发生脑梗死。第Ⅲ疗程后出现呼吸困难,休息可缓解;3d后夜间活动突然呼吸困难,死于呼吸循环衰竭。尸检:卵巢透明细胞癌盆腹腔广泛转移,巨块型肺动脉血栓栓塞(血栓长20cm),脑梗死。妇科恶性肿瘤患者在围手术期和化疗过程中属于静脉血栓形成和肺栓塞的危险人群,应该适当给予预防性抗凝治疗。 A60year-old female complained with abdominal distension for one month.StageⅢc,grade2clear cell carcinoma of the ovary was diagnosed after laparotomy.Weekly paclitaxel combined with carboplatin as adjuvant chemotherapy was given after optimal cytoreductive surgery.An acute cerebral infarction after first chemotherapy cycle was developed.The patient presented with dyspnoea after the third chemotherapy cycle and the symptom could be relieved at rest.Such symptom worsened and relieved alternatively for3days.A sudden dyspnoea occurred to the patient again when she got up one night,an d died of respiratory and circulatory failure on the way to the hospital.Autopsy revealed ovarian clear cell carcinoma with metastasis to the whole pelvic and abdominal cavity and massive pulmonary arterial embolism(the length of embolus is20cm)with cerebral infarction.A conclusive remarks was made during the conference that patients who underwent operation and chemotherapy were at high risk for venous thrombosis (VT)and pulmonary embolism (PE).It was important to analyze a patient' s individual risk for VT and PE.Appropriate thrombosis prophylaxis ought to be considered highly for high risk patients.
出处 《中国医学科学院学报》 CAS CSCD 北大核心 2003年第4期471-475,共5页 Acta Academiae Medicinae Sinicae
关键词 卵巢肿瘤 肺栓塞 临床病理讨论 ovarian carcinoma pulmonary embolism clinicopathological conference
  • 相关文献

参考文献14

  • 1金力,沈铿,郎景和,黄惠芳,潘家琦,戴晴,王书杰.妇科肿瘤术后并发深静脉血栓的诊治与预防[J].中华妇产科杂志,1999,34(8):488-490. 被引量:140
  • 2石敏,张羽,沈铿,郎景和,黄惠芳,吴鸣.卵巢透明细胞癌的临床特点[J].中华妇产科杂志,2002,37(3):161-163. 被引量:15
  • 3McGuire WP, Hoskins WJ, Brady MF, et al. Cyclophosphamide and cisplatin compared with paclitaxel knd cisplatin in patients with stage Ⅲ and stage Ⅳ ovarian cancer. N Engl J Med, 1996, 334(1):1-6.
  • 4European Consensus Statement on the prevention of venous thromboembolism. Int Angiol, 1992, 11 : 151-156.
  • 5Gamble GE, Tyrrell P. Acute stroke following cisplatin therapy. Clin Oncol (R Coil Radiol), 1998, 10(4):274-275.
  • 6Nomura K, Ohno R, Hamaguchi K, et al. Clinicopathological report of cisplatin encephalopathy. Rinsho Shinkeigaku, 1995, 35(1):64-69.
  • 7Lyass O, Lossos A, Hubert A, et al. Cisplatin-induced non-convulsive encephalopathy.Anticancer Drugs, 1998, 9(1):100-104.
  • 8El Amrani M, Heinzlef O, Debroucker T, et al. Brain infarction following 5-fluorouracil and cisplatin therapy.Neurology, 1998, 51(3) :899-901.
  • 9Chan AT, Leung WT, Johnson PJ. Cerebrovascular event following taxol infusion.Clin Oncol (R Coll Radiol), 1994,6(3) : 202-203.
  • 10Sevelda P, Mayerhofer K, Obermair A, et al. Thrombosis with paclitaxel. Lancet, 1994, 343(8899):727.

二级参考文献12

  • 1吴阶平,黄家驷外科学(第5版),1992年,437页
  • 2Hart WR. Pathology of malignant and borderline (low malignant potential) epithelial tumors of ovary. In: Coppleson M, ed. Gynecologic oncology fundamental principles and clinical practice. New York: Churchill Livingstone, 1992. 863-887.
  • 3Thingpen JT, Blessing JA, Ball H, et al. Phase Ⅱ trial of paclitaxel in patients with progressive ovarian carcinoma after platinum-based chemotherapy: a Gynecologic Oncology Group study. J Clin Oncol, 1994, 12: 1748-1753.
  • 4Sugiyama T, Kamura T, Kigawa J, et al. Clinical characteristics of clear cell carcinoma of the ovary: a distinct histologic type with poor prognosis and resistant to platinum-based chemotherapy. Cancer, 2000, 88: 2584-2589.
  • 5Kita T, Kikuchi Y, Kudoh K, et al. Exploratory study of effective chemotherapy to clear cell carcinoma of the ovary. Oncol Rep, 2000, 7: 327-331.
  • 6Behbakht K, Randall TC, Benjamin I, et al. Clinical characteristics of clear cell carcinoma of the ovary. Gynecol Oncol, 1998, 70: 255-258.
  • 7Jenison EL, Montag AG, Griffiths CT, et al. Clear cell adenocarcinoma of the ovary: a clinical analysis and comparison with serous carcinoma. Gynecol Oncol, 1989, 32: 65-71.
  • 8Goff BA, Sainz de la Cuesta R, Muntz HG, et al. Clear cell carcinoma of the ovary: a distinct histologic type with poor prognosis and resistance to platinum-based chemotherapy in stage Ⅲ disease. Gynecol Oncol, 1996, 60: 412-417.
  • 9Gorai I, Nakazawa T, Miyagi E, et al. Establishment and charac- terization of two human ovarian clear cell adenocarcinoma lines from metastatic lesions with different properties. Gynecol Oncol, 1995, 57: 33-46.
  • 10Shimizu Y, Umezawa S, Hasumi K. A phase Ⅱ study of combined CPT-11 and mitomycin-C in platinum refractory clear cell and mucinous ovarian carcinoma. Ann Acad Med Singapore, 1998, 27: 650-656.

共引文献153

同被引文献14

  • 1张丽辉,许凤芝.恶性肿瘤的凝血异常[J].现代康复,1998,2(6):562-564. 被引量:12
  • 2吴明,纪勤炯,王安才.腹部肿瘤致肺栓塞1例报告[J].皖南医学院学报,2005,24(2):158-158. 被引量:1
  • 3梁完坤.年轻人高血压脑出血临床特点[J].中华神经医学杂志,2006,5(7):731-732. 被引量:14
  • 4Nomura K,Ohno R,Hamaguchi K,et a1.C1inicopathological report ofcisplatin encephalopathy[J].Rinsho Shinkeigaku,1995,35(1):64-69.
  • 5Gamble GE,Tyrrell P.Acute stroke following cisplatin therapy[J].Clin Oncol(R Coll Radiol),1998,10(4):274-275.
  • 6El Amrani M,Heinzlef O,Debroucker T,et al.Brain infarctionfollowing 5-fluorouracil and cisplatin therapy[J].Neurology,1998,51(3):899-901.
  • 7Lyass O,Lossos A,Hubert A,et al.Cisplatin-induced non-convulsiveencephalopathy[J].Anticancer Drugs,1998,9(1):100-104.
  • 8Chan AT,Leung WT,Johnson PJ.Cerebrovascular event followingtaxol infusion[J].Cl in Oncol(R Coll Radiol),1994,6(3):202-203.
  • 9Sevelda P,Mayerhofer K,Obermair A,et a1.Thrombosis withpaclitaxel[J].Lancet,1994,343(8899):727.
  • 10Mayerhofer K,Bodner K,Saletu B,et al.Paclitaxel does not causecentral nervous adverse effects:a prospective vigilance-controlledEEC mapping study in ovarian cancer patients[J].Wien KlinWochenschr 2000,112(23):1007-1013.

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部